Abstract
The aim of this chapter is to give an overview on pain management in patients treated in radiation oncology. This chapter addresses the diverse symptom complex of pain in patients suffering from advanced cancer, while these symptoms may or may not be clearly associated with radiotherapy. Pain is one of the most challenging and most important symptoms among cancer patients and poses a complex problem with many different components, e.g., emotional, physical, and social, and may cause considerable distress and suffering throughout the course of disease and the applied therapies.
Radiotherapy may be utilized to relieve symptoms of pain; some patients have preexisting pain resulting from the advanced disease or from comorbidities. However, pain may also be an important side effect of different therapeutic approaches, also of radiotherapy. Therefore supportive strategies should be interdisciplinary and equally multimodal to address this complexity. This chapter focuses on proposing practical advice for optimizing pain management in radiation oncology based on actual guidelines and reviews (Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Langversion 1.0, 2015, AWMF-Registernummer: 128/001OL, http://leitlinienprogramm-onkologie.de/Palliativmedizin.80.0.html, 2015; Deutsche Gesellschaft für Schmerzmedizin (DGS) PraxisLeitlinie Tumorschmerz V 2.0, https://dgschmerzmedizin.de/praxisleitlinien/Tumorschmerz.pdf, 2014; Sawhney et al., Guidelines on Management of Pain in Cancer and/or Palliative Care. Cancer Care Ontario, https://archive.cancercare.on.ca/common/pages/UserFile.aspx?fileId=384144, 2017; Fallon et al., Ann Oncol 29(4):iv149–iv174, 2018).
This is a preview of subscription content, log in via an institution.
References
Bennett MI, et al. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: a systematic review. Palliat Med. 2011;25(5):553–9.
Bjorkman R, Ullman A, Hedner J. Morphine-sparing effect of diclofenac in cancer pain. Eur J Clin Pharmacol. 1993;44(1):1–5.
Bucci MK, et al. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin. 2005;55(2):117–24.
Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on cancer pain. International Association for the study of pain. Pain. 1999;82:263–74.
Caraceni A, Cherny N, Fainsinger R, et al. Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. J Pain Symptom Manag. 2002;23(3):239–55. Review.
Caraceni A, et al. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the gabapentin cancer pain study group. J Clin Oncol. 2004;22(14):2909–17.
Caraceni A, Pigni A, Brunelli C. Is oral morphine stull the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project. Paliat Med. 2011;25(5):402–9.
Chang HC, et al. Evaluation of pain intensity assessment tools among elderly patients with cancer in Taiwan. Cancer Nurs. 2017;40(4):269–75.
Chow R, Hoskin P, Chan S, et al. Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: a systematic review. Radiother Oncol. 2017a;122(3):323–31.
Chow R, Hoskin P, Hollenberg D, et al. Efficacy of single fraction conventional radiation therapy for painful uncomplicated bone metastases: a systematic review and meta-analysis. Ann Palliat Med. 2017b;6(2):125–42.
Deandras S, et al. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19(12):1985–91.
Duarte-Souza JF, et al. Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better. Support Care Cancer. 2007;15(11):1319–23.
Fallon M. Neuropathic pain in cancer. Br J Anaesth. 2013;111:105–11.
Fallon M, Giusti R, Aielli F, et al. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(4):iv149–74.
Ferrel B, Argoff CE, Epplin J, Fine P, Gloth FM, Herr K, Katz JD, Mehr DR, Reid C, Reisner L. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331–46.
Ferrer-Brechner T, Ganz P. Combination therapy with ibuprofen and methadone for chronic cancer pain. Am J Med. 1984;77(1A):78–83.
Goudas LC, Bloch R, Gialeli-Goudas M. The epidemiology of cancer pain. Cancer Investig. 2005;23:182–90.
Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain. 1986;25(3):297–312.
Johansson S, et al. Timescale of evolution of late radiation injury after postoperative radiotherapy of breast cancer patients. Int J Radiat Oncol Biol Phys. 2000;48(3):745–50.
Körner P, Ehrmann K, Hartmannsgruber J, et al. Patient -reported symptoms during radiotherapy: clinically relevant symptom burden in patients treated with palliative and curative intent. Strahlenther Onkol. 2017;193(7):570–7.
Lagger V, Mahrer R, Imhof L. Pain management in patients with cognitive impairment: a research implementation project. Pflege. 2008;21(3):149–56.
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung, Langversion 1.0, 2015, AWMF-Registernummer: 128/001OL, http://leitlinienprogramm-onkologie.de/Palliativmedizin.80.0.html
Lim FMY, Bobrowski A, Agarwal A, et al. Use of corticosteroids for pain control in cancer patients with bone metastases: a comprehensive literature review. Curr Opin Support Palliat Care. 2017;11(2):78–87. Review.
Lutz S, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys. 2011;79(4):965–76.
Lyne ME, et al. Pain management issues for cancer survivors. Cancer Pract. 2000;10(Suppl 1):S27–32.
McCaffrey M. Nursing management of the patient in pain. Philadelphia: J B Lippincott; 1972.
McNicol E, et al. NSAIDS or paracetamol, alone or in combined with opioids, for cancer pain. Cochrane Database Syst Rev. 2005;(1):CD005180.
Menshawy A, Mattar O, Abdulkarim A, et al. Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials. Support Care Cancer. 2018;26(4):1029–38.
Mercadante S, et al. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori. 2002;88(3):239–42.
Merskey H, Bogduk N. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle: International Association for the study of pain Press; 1994.
Mueller G, Schumacher P, Holzer E, et al. The inter-rater reliability of the observation instrument for assessing pain in elderly with dementia: an investigation in the long-term care setting. J Nurs Meas. 2017;25(3):173–84.
Niglas M, Raman S, Rodin D, et al. Should dexamethasone be standard in the prophylaxis of pain flare after palliative radiotherapy for bone metastases?-a debate. Ann Palliat Med. 2018;7(2):279–83.
Paice JA, Portenoy R, Lacchetti C, et al. Management of chronic pain in survivors of adult cancers: American Society of clinical oncology clinical practice guideline. J Clin Oncol. 2016;34(27):3325–45.
Portenoy RK. Treatment of cancer pain. Lancet. 2011;377:2236–47.
Rodriguez M, et al. Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain. Eur J Cancer. 1994;30A(5):584–7.
Rodriguez RF, et al. Incidence of weak opioids adverse events in the management of cancer pain: a double-blind comparative trial. J Palliat Med. 2007;10(1):56–60.
Saito T, Tomitaka E, Toya R, et al. A neuropathic pain component as a predictor of improvement in pain interference after radiotherapy for painful tumors: a secondary analysis of a prospective observational study. Clin Transl Radiat Oncol. 2018;12:34–9.
Saunders C. The evolution of palliative care. J R Soc Med. 2001;94(9):430–2.
Sawhney M, Fletcher G, Rice J, et al. (2017) Guidelines on management of pain in cancer and/or palliative care. Cancer Care Ontario, https://archive.cancercare.on.ca/common/pages/UserFile.aspx?fileId=384144
Ventafridda V, et al. A validation study of the WHO method for cancer pain relief. Cancer. 1987;59(4):850–6.
Weingart WA, Sorkness CA, Earhart RH. Analgesia with oral narcotics and added ibuprofen in cancer patients. Clin Pharm. 1985;4(1):53–8.
Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2007;(4):CD003868.
World Health Organization. WHO guidelines: cancer pain relief. 2nd ed. Geneva: World Health Organization; 1996.
Yalcin S, et al. Ketoolac tromethamine in cancer pain. Acta Oncol. 1997;36(2):231–2.
Yalcin S, et al. A comparison of two nonsteroidal anti-inflammatory drugs (diflunisal versus dipyrone) in the treatment of moderate to severe cancer pain: a randomized crossover study. Am J Clin Oncol. 1998;21(2):185–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Flörcken, A., Roch, C., van Oorschot, B. (2019). Pain Management. In: Wenz, F. (eds) Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-52619-5_113-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52619-5_113-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52619-5
Online ISBN: 978-3-319-52619-5
eBook Packages: Springer Reference MedicineReference Module Medicine